Genericon Pharma has joined Pharma.Aero’s Life Science Manufacturers Advisory Platform (LMAP), a global initiative aimed at strengthening collaboration and innovation across pharmaceutical logistics.
The Austrian-based company, with nearly 40 years of experience in the industry, is recognized for its commitment to developing and delivering safe, effective, and accessible medicines. Its portfolio covers a wide range of therapeutic areas, including cardiovascular health, metabolism, neurology, and psychiatry.
Becoming a member of PharmaAero engages Genericon Pharma to shape best practices for pharmaceutical logistics. For Genericon the involvement means valuable opportunities for meaningful contributions to the industry. We look forward working together with other members to advance our knowledge and connect with key stakeholders.
Genericon’s membership strengthens the reach of LMAP, a platform that brings together manufacturers, logistics providers, airports, and other stakeholders to foster collaboration and drive improvements in global life sciences supply chains.
By contributing its expertise and experience, Genericon Pharma is expected to play a role in advancing best practices for the secure and efficient transport of medicines worldwide.